Tobramycin is a suppressor of premature termination codons

Slides:



Advertisements
Similar presentations
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Advertisements

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Poor growth in an infant with cystic fibrosis due to an antenatal perforation and incomplete bowel obstruction  Isobel Brookes, Maya Desai, Gillian Duthie,
Tsai-Der Chuang, Ph.D., Omid Khorram, M.D., Ph.D. 
Treatment compliance in children and adults with Cystic Fibrosis
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis  P. McNally, C. Coughlan,
Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients  Francesca Megiorni, Samantha Cialfi, Giuseppe Cimino, Riccardo.
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Anti-inflammatory effect of miglustat in bronchial epithelial cells
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue.
Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Cirrhosis and other liver disease in cystic fibrosis
The Pattern Recognition Receptor NOD2 Mediates Staphylococcus aureus–Induced IL- 17C Expression in Keratinocytes  Sarah A. Roth, Maren Simanski, Franziska.
Molecular and Functional Analysis of the Large 5′ Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders  Sonia Giordano,
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Prenatal diagnosis for CF using High Resolution Melting Analysis and simultaneous haplotype analysis through QF-PCR  Myrto Poulou, Aspasia Destouni, Georgia.
A.H. Gifford  Journal of Cystic Fibrosis 
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis  Abdul Ashish, Steve.
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Feasibility of parental collected nasal swabs for virus detection in young children with cystic fibrosis  C.L. Gangell, C. Shackleton, S. Poreddy, J.
Felix Ratjen, Florian Brockhaus, Gerhild Angyalosi 
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Antine E. Stenbit, Wendy M. Bullington, Julie L. Heh, Patrick A. Flume 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid  Jürgen Harder, Ulf Meyer-Hoffert,
Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Volume 39, Issue 5, Pages (November 2003)
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
Volume 61, Issue 5, Pages (May 2002)
Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test  Karoline Droebner, Peter Sandner  Journal.
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Nuclear Localization and Transcriptional Repression Are Confined to Separable Domains in the Circadian Protein CRYPTOCHROME  Haisun Zhu, Francesca Conte,
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Nuclear Localization and Transcriptional Repression Are Confined to Separable Domains in the Circadian Protein CRYPTOCHROME  Haisun Zhu, Francesca Conte,
Nonsense-mediated mRNA decay
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Haisun Zhu, Carla B. Green  Current Biology 
Presentation transcript:

Tobramycin is a suppressor of premature termination codons Nicola Altamura, Rosa Castaldo, Alessia Finotti, Giulia Breveglieri, Francesca Salvatori, Cristina Zuccato, Roberto Gambari, Giulia Chiara Panin, Monica Borgatti  Journal of Cystic Fibrosis  Volume 12, Issue 6, Pages 806-811 (December 2013) DOI: 10.1016/j.jcf.2013.02.007 Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Read-through properties of Tobramycin, Gentamicin and G418 at a premature termination codon relative to NMD+ untreated yeasts (0 NMD+). A dual-luciferase reporter plasmid expressing the Renilla and Firefly luciferase open reading frames, separated by the UAG stop codon or the CAG sense codon [11] was introduced into yeast strains with either functional (NMD+, left side) or abolished NMD (NMD−, right side). Transformants were growth, either in the absence or in the presence of the indicated concentrations of the aminoglycosides A) Tobramycin, B) Gentamicin or C) G418. Yeast lysates were prepared for a dual-luciferase reporter assay. Read-through percentages were calculated as the nonsense Firefly/Renilla activity ratio normalized to the sense Firefly/Renilla activity ratio×100 and reported relative to control (untreated yeasts, NMD+) set arbitrarily to 1. Mean±SD values were determined for each percentage activity for at least four independent experiments. *p<0.05 by Student t test. D. Analysis of the firefly luciferase (left side) and CAN1-100 (right side) mRNA levels in yeast by real time PCR. Yeasts, with active (NMD+) or abolished NMD (NMD−), carry firefly luciferase gene with UAG nonsense codon (black boxes) or CAG sense codon (white boxes) and CAN1-100 (CAN1 gene with nonsense codon). Data represent the average of three independent experiments±SD. Journal of Cystic Fibrosis 2013 12, 806-811DOI: (10.1016/j.jcf.2013.02.007) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Read-through relative to NMD+ untreated yeasts or NMD− untreated yeasts of Tobramycin, Gentamicin and G418 at nonsense codons in yeast strains with either functional or abolished NMD. Yeast strains with functional (NMD+, on the left) or abolished NMD (NMD−, on the right) were transformed with a dual-luciferase reporter plasmid in which the two luciferases were separated by A) UAG stop codon or CAG sense codon; B) UGA stop codon or CGA sense codon; and C) UAA stop codon or CAA sense codon. Read-through percentages, calculated as the nonsense Firefly/Renilla activity ratio normalized to the sense Firefly/Renilla activities ratio×100, are reported relative to NMD+ untreated yeasts (0 NMD+) or NMD− untreated yeasts (0 NMD−). Mean±SD values were determined for each percentage activity for at least four independent experiments. *p<0.05 by Student t test. Journal of Cystic Fibrosis 2013 12, 806-811DOI: (10.1016/j.jcf.2013.02.007) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions